Investor
Cue said it made the decision due to larger economic challenges and the federal government's recent move to divert funding from COVID-19 tests.
The startup's data platform aims to help clients like providers and payers understand how social factors are impacting patient health.
The merger with its principal shareholder TPG Capital is expected to close in the second half of 2022.
In February, Ro announced a $150 million fundraise that bumped its valuation to $7 billion.
Also: Fertility startup AiVF scores $25 million, and caregiver financial-support platform Aidaly emerges from stealth with $8.5 million.
SteadyMD announced a $25 million Series B raise in March 2021.
Florence announced it had raised $80 million in its Series C round in May 2021.
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.